Why the study?
Does scintigraphy combined with hormonal assessment help differentiate benign from malignant adrenal incidentalomas and assess functional status?
Does scintigraphy combined with hormonal assessment help differentiate benign from malignant adrenal incidentalomas and assess functional status?
Morphofunctional examination by scintiscan provides valuable data regarding the likelihood of malignancy in adrenal incidentalomas, whereas endocrine testing alone fails to differentiate benign from malignant tumors.
Authors
No takes yet. Share an insight, caveat, or question.
Scintigraphy may complement hormonal assessment for unilateral adrenal incidentalomas; hypothesis-generating and requires prospective validation before practice change.
Luisa Barzon (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: